TRi-1

• Description :

  TRi-1 is irreversible inhibitor of cytosolic thioredoxin reductase 1 (TXNRD1) with an IC50 of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  328.72

• Molecular Formula :

  C12H9ClN2O5S

• Notes :

  Research use only, not for human use.

• Receptor :

  TXNRD1

• CAS Number :

  246020-68-8